Getein Biotech(SH:603387) Zheng Quan Zhi Xing·2025-09-04 10:07Core Points - Getein Biotech, Inc. is holding its first extraordinary general meeting of shareholders in 2025 to discuss several key proposals aimed at improving corporate governance and operational efficiency [1][3][4] Group 1: Meeting Proposals - Proposal 1 involves the cancellation of the supervisory board and the amendment of the company's articles of association to enhance governance structure [3][4] - Proposal 2 includes multiple amendments to governance-related systems, such as the rules for board meetings, shareholder meetings, and the independent director work system [1][3][4] - The meeting will also address the abolition of the supervisory board's procedural rules and the revision of the external guarantee management system [1][3][4] Group 2: Meeting Procedures - The meeting is scheduled for September 15, 2025, at 14:00, and will be held both in-person and via an online voting system [2][3] - Shareholders must register and provide identification to participate, and they will have the right to speak and vote on the proposals presented [2][3] - Voting will be conducted through a named voting method, and all proposals will require a clear choice of "agree," "disagree," or "abstain" [2][3][4] Group 3: Governance Changes - The proposed changes aim to align the company's governance with the requirements of the Company Law and Securities Law of the People's Republic of China [3][4] - The amendments are designed to protect the rights of shareholders and ensure the company's operations are conducted in a transparent and efficient manner [3][4] - The company emphasizes the importance of maintaining order during the meeting and protecting the rights of all shareholders present [2][3]